08/02/2013
CURRICULUM VITAE
Name:
Marvin Stanley Swartz, M.D.
Address:
2500 Alpine Road, Durham, NC 27707
Phone:
Office: (919)684-8676
Home: (919)489-0733
Date of Birth: October 8, 1950 - Boston, Massachusetts
Citizenship:
United States
Marital Status: Married, 1979, two children
Education:
1968-72
1973-75
1976-80
1980-81
1981-84
1986-91
Harvard College, Cambridge, MA. A.B., cum laude (Social Relations).
Harvard College, Cambridge, MA. Special graduate studies, (pre-medical).
Tufts University School of Medicine, Boston, MA. M.D.
Intern, University of Hawaii Integrated Flexible Program, Honolulu, Hawaii.
Resident, Department of Psychiatry, Duke University Medical Center, Durham, NC.
Duke University School of Medicine, Durham, NC. Course work for Masters in
Health Science (Biometry)
Physician's Certification:
Diplomate, National Board of Medical Examiners
Licensee, Board of Medical Examiners of State of NC
Board Certified, American Board of Psychiatry and Neurology
Distinguished Fellow, American Psychiatric Association
Positions Held:
1982-88
1984-92
1984-85
19841985-87
Consulting Psychiatrist, North Carolina Department of Corrections.
Assistant Medical Director, Acute Psychiatric Service, Duke University Medical
Center.
Associate in Psychiatry, Division of Social and Community Psychiatry, Duke
University Medical Center.
Co-Investigator, Duke University Epidemiologic Catchment Area Project.
Director of Training, Division of Social and Community Psychiatry, Duke
1
1985-86
1985-90
1986-87
1986-92
198719901995-99
19991992199519961996-97
199720032008-10
2009-10
University Medical Center.
Medical Director, Acute Psychiatric Service and Personality Studies Unit, Duke
University Medical Center.
Assistant Professor of Psychiatry, Division of Social and Community Psychiatry,
Duke University Medical Center.
Director, Emergency Psychiatry Service, Duke University Medical Center.
Assistant Clinical Director, Psychiatry Inpatient Service, Duke University Medical
Center.
Head, Division of Social and Community Psychiatry, Duke University Medical
Center.
Associate Professor of Psychiatry, Division of Social and Community Psychiatry,
Duke University Medical Center.
Associate Professor of Psychiatry & Behavioral Sciences, with tenure, Duke
University Medical Center.
Professor of Psychiatry & Behavioral Sciences, with tenure, Duke University
Medical Center.
Vice-Chairman for Clinical Services, Dept. of Psychiatry, Duke University Medical
Center.
Research Fellow, Cecil G. Sheps Center for Health Services Research, UNC-Chapel
Hill
Senior Fellow, Center for Health Policy Research and Education, Duke University
Interim Director, Duke Area Health Education Center
Director, Duke Area Health Education Center
Senior Research Fellow, Duke University Health Inequalities Program
Executive Vice-Chairman, Dept. of Psychiatry, Duke University Medical Center
Interim Chairman, Dept. of Psychiatry, Duke University Medical Center
Societies:
American Psychiatric Association
North Carolina Psychiatric Association
American Academy of Psychiatry and Law
American Public Health Association
American Psychopathological Association
American College of Mental Health Administration
Honors:
1971
1980
1983
1986-87
John Harvard Book Award (Harvard College).
Alpha Omega Alpha (Tufts University School of Medicine).
Resident Achievement Award, North Carolina Neuropsychiatric Association.
Honored Teacher Award, Department of Psychiatry, Duke University Medical
Center.
2
1992
1994
1994
1996
1996
1996
1996
1996
1997
1997
2000
2003
2004
2006
2008
2011
2012
Exemplary Psychiatrist Award, National Alliance for the Mentally Ill
Gold Apple, National Education Film & Video Festival (for Hospital Without
Walls)
Finalist, International Health & Medical Film Festival (for Hospital Without Walls)
Finalist, Telly Awards (for Uncertain Journey: Families Coping with Serious
Mental Illness)
Gold CINDY (Cinema in Industry) certificate, International Association of Audio
Visual Communicators (for Uncertain Journey: Families Coping with Serious
Mental Illness)
First Place Award - Patient Care Category, FREDDIE award, American Medical
Association International Health & Medical Film Festival (for Uncertain Journey:
Families Coping with Serious Mental Illness)
Bronze Plaque Award, The Film Council of Greater Columbus/44th Columbus
International Film & Video Festival (for Uncertain Journey: Families Coping with
Serious Mental Illness)
Bronze Apple Award, National Educational Media Network (for Never Too Far:
Rural Outreach for Serious Mental Illness)
Exemplary Psychiatrist Award, National Alliance for the Mentally Ill
Eugene A. Hargrove Mental Health Research Award
Finalist Certificate, The New York Festivals Film & Video (Non-Broadcast)
Competition (for Go For It: A Future in Healthcare)
Distinguished Fellow, American Psychiatric Association
RTPnet Community Technology Award (with Topsail Technologies, Inc.) for
Polyglot 2.0: Multimedia Medical Spanish Translator
Eugene A. Hargrove Mental Health Research Award
President’s Award (for leadership in academic and community psychiatry), N.C.
Psychiatric Association
Carl Taube Award for Distinguished Contributions to Mental Health Services
Research, American Public Health Association
Senior Scholar, Health Service Research Award, American Psychiatric Association
Professional and Educational Activities:
Advisory Boards and Committees:
Duke University Medical Center:
1993
Member, Physician Leadership Group for Managed Care
1993
Member, Primary Care Operations and Planning Committee
1993-96 Member, Clinical Practice Committee
1995-96 Member, Private Diagnostic Clinic Operating Committee
2009-10 Member, Private Diagnostic Clinic, Clinical Affairs Committee
2011Member, Private Diagnostic Clinic, Clinical Oversight Committee
2011Member, Private Diagnostic Clinic, Pharmacy Workgroup Committee
3
Community/Organizations:
1985-87 Board Member, Helpline, Durham, NC
1985-87 Board of Directors, Threshold, Inc., Durham, NC
1992-94 Member, Diagnostic and Statistical Manual IV, Axis II, Advisory Board, American
Psychiatric Association
1992-93 Chairman, Distinguished Citizens Advisory Group on Mental Illness Insurance
Study, North Carolina Alliance for the Mentally Ill
1993-95 Board Member, N. C. Alliance for the Mentally Ill Advisory Board, Raleigh, NC
1993
Member, Little Rock Working Group on Mental and Substance Abuse Disorders in
Health Care Reform
1993-94 Member, Integrated Funding Implementation Advisory Committee, N.C. Division
of Human Resources, Division of Mental Health, Developmental Disabilities, and
Substance Abuse Services
1993-94 Member, Nominating Committee, N. C. Psychiatric Association
1994
Chair, Program Committee, N. C. Psychiatric Association.
1995Member, Board of Trustees, Fayetteville Area Health Education Foundation.
1995-97 Member, Advisory Board, NC Alliance for the Mentally Ill
1998Member, Board of Directors, N.C. Foundation for Mental Health Research, Inc.
1999
Chair, Program Committee, North Carolina Psychiatric Association.
2000
Consultant to N.C. Institute of Medicine & N.C. State Auditor’s Office for
Auditor’s Report on the N.C. Mental Health System
1999-99 Member, N.C. Division of Health & Human Services, Advisory
Committee for N.C. State Mental Health Reform Plan
2000
Member, Search Committee, N.C. Director of the Division of MH/DD/SA Services
2001
Member, N.C. Commission for MH/DD/SA Services
2002–07 Member, American Psychiatric Association Council on Quality Care
2005Member, N.C. Institute of Medicine
2006
Member, Psychiatric Services Editorial Board
2006
Chair, Advisory Committee, N.C. Commission for MH/DD/SA Services
2006
Member NC Institute of Medicine, Taskforce on Primary and Specialty Care
2000- 11 Member, MacArthur Foundation Research Network on Mandated Community
Treatment, MacArthur Foundation
2011Member, NC Institute of Medicine, Taskforce on Health Care Reform
Grant and Contract Support:
1. Developing a Screening Index for Borderline Personality Disorder. Grant from AW Mellon
Foundation to Duke University Medical Center Clinical Epidemiology Unit. Small grant
investigator, 1987.
2. Risk Factors for Psychiatric Disorders. NIMH
P.I. Linda George, Ph.D. Co-investigator, July 1988 - July 1991.
4
3. Training Curriculum for Mental Health Professionals Working with Severe and Persistent
Mental Illness. Contract with N.C. Division of Mental Health, Mental Retardation, and
Substance Abuse, 1989.
4. Collaborating with Families with Severe and Persistent Mental Illness.
Contract with N.C. Area Health Education Centers and N.C. Division of
Mental Health, Mental Retardation, and Substance Abuse, 1989-1990.
5. Epidemiology: Alcohol, Drug Abuse and Mental Disorders, NIMH.
P.I. Ron Kessler, Ph.D.; Consultant to National Comorbidity Study Research. Advisory Group,
October 1989-September 1994.
6.
Research Training in Mental Health Services and Systems, NIMH.
Program Director, Joseph Morrissey, Ph.D.; Program Faculty, 1990-1993.
7.
The Effectiveness of Involuntary Outpatient Commitment, NIMH.
P.I. Marvin Swartz, M.D., 1992-1999.
8.
Program on Services Research for People with Severe Mental Disorders, NIMH.
P.I. Joe Morrissey, Ph.D.; Co-Director, 1993-1998.
9.
Research Study on Involuntary Outpatient Mental Health Treatment, State of New York
P.I. Hank Steadman, Ph.D.; Co-P.I., 1995-1999.
10.
Assessing HIV and Associated Health Risks in People with Severe Mental Illness, NIMH
P.I. Marvin Swartz, M.D., 1996-1999.
11.
HIV Seroprevalence and Risks in Veterans with Severe Mental Illness, V.A.
P.I. Marian Butterfield, M.D., MPH; Consultant, 1998-2001.
12.
Schizophrenia Care & Assessment Program, Eli Lilly & Co.
P.I. Jeffrey Swanson, Ph.D.; Co-P.I., 1997-2002.
13.
Better Specifying the Relationship Between Clinical Characteristics, Illicit Drug Use and
Treatment Outcomes in Schizophrenia, Stanley Foundation
P.I. Marvin Swartz, M.D., 1998-2000.
14.
Relationship of Stress Exposure to Health in Gulf War Veterans, Dept. of Defense
P.I. John Fairbank, Ph.D.; Co-Investigator, 1998-2002.
15.
A HIV-AIDS Treatment Adherence, Health Outcomes and Cost Study, SAMSHA
P.I. Kate Whetten-Goldstein, Ph.D.; Co-P.I., 1998-2003.
5
16.
The Effectiveness of Involuntary Outpatient Commitment, Competing Continuation, NIMH
P.I. Marvin Swartz, M.D. 1999-2002.
17.
Clinical Antipsychotic Trials of Intervention Effectiveness, NIMH
P.I. Jeff Lieberman, M.D.; Co-P.I., 1999-2005; 2005-2009.
18.
Formats for Assessing HIV Risk in Severely Mentally Ill People, NIMH
P.I. George Wolford, Ph.D.; Co-Investigator, 1999-2001.
19.
MacArthur Foundation Initiative on Mandated Community Treatment, MacArthur Foundation
P.I. John Monahan, Ph.D.; Investigator, 2000-2005.
20.
Coping with HIV/AIDS in the Rural South. NIMH
P.I. Kate Whetten, Ph.D.; Co-Investigator, 2001-2006.
21.
Implementing Psychiatric Advance Directives Among Recently-Hospitalized Patients Under
Outpatient Commitment, MacArthur Foundation
P.I. Jeffrey Swanson, Ph.D.; Co-P.I., 2003-2006.
22.
Duke Program on Psychiatric Advance Directives, Greenwall Foundation
P.I. Marvin Swartz, M.D., 2003-2005.
23.
Stability and Long-term Outcomes of Psychiatric Advance Directives, MacArthur Foundation
P.I. Jeffrey Swanson, Ph.D.; Co-P.I., 2006.
24.
Assisted Outpatient Treatment Evaluation Services, MacArthur Foundation
P.I. Marvin Swartz, M.D., 2006-2009.
25.
Effectively Implementing Psychiatric Advance Directives, NIMH
P.I. Jeffrey Swanson, Ph.D.; Co-PI, 2002-2006.
26.
Schizophrenia Trials Network, NIMH
P.I. T. Scott Stroup, M.D.; Co-Investigator, 2005-2010.
27.
Building a Virtual Resource Center for Psychiatric Advance Directives and Self-directed Care,
MacArthur Foundation
P.I., Marvin Swartz, M.D.; 2005-2008.
28.
Comparison of Antipsychotics for Metabolic Problems, F-NIH,
P.I. T. Scott Stroup, M.D.; Co-Investigator, 2005-2010.
29.
Evaluation of Assisted Outpatient Treatment, New York State Office of Mental Health
6
P.I. Marvin Swartz, M.D., 2006-2009.
30.
Improving Representative Payeeship for People with Psychiatric Families and their Families
P.I. Jeffrey Swanson, Ph.D.; Co-Investigator, 2007-2009.
31.
Cost of Criminal Justice Involvement Among Persons with SMI in Connecticut
P.I. Jeffrey Swanson, Ph.D.,; Co-Investigator, 2007-2009
32.
Quantifying Costs & Benefits of Outpatient Commitment and Psychiatric Advance Directives
P.I. Jeffrey Swanson, Ph.D.; Co-Investigator, 2008-2009
33.
Assessing & Reducing Post-Deployment Violence Risk
P.I. Marvin Swartz, M.D., 2008-2009
34.
Gillings Innovation Lab for Mental Health System Improvement (GIL)
P.I. Marvin Swartz, M.D., 2008-2010
35.
Comparison of Optimal Antipsychotic Treatments for Schizophrenia (COATS)
P.I. Joseph McEvoy, M.D.; Co-Investigator, 2008-2009.
36.
A Comparison of Long-Acting Injectable Medications for Schizophrenia (ACLAIMS)
P.I. Joseph McEvoy, MD; Co-Investigator, 2009-2014.
37.
Collaborative HIV-AIDS Prevention & Mental Health Treatment
P.I. Susan Reiff, Ph.D.; Investigator, 2009-2011
38.
Community Re-entry of Persons with Severe Mental Illness
P.I. Joseph Morrissey, PhD (UNC); Investigator, 2011-1012
39.
Firearms, Laws, Mental Disorder and Violence
P.I. Jeffrey Swanson, PhD; Investigator, 2011-2012
40.
Do Brief Incarcerations Before Jail Diversion Enhance Legal Leverage and Improve Outcomes
Among People with Serious Mental Illness in CT?
P.I. Allison Robertson, Ph.D.; Investigator, 2011-2013
Reviewer and Editorial Boards:
Reviewer:
1987198819891989-
American Journal of Public Health
Journal of American Medical Association
Psychosomatics
Psychosomatic Medicine
7
1989198919911992199219931996199620002000200120022002-
Journal of Nervous and Mental Disease
International Journal of Psychiatry in Medicine
American Journal of Psychiatry
Journal of Personality Disorders
American Journal of Geriatric Psychiatry
Health Services Research
Milbank Quarterly
Harvard Review of Psychiatry
Schizophrenia Bulletin
Psychiatric Services
European Archives of Psychiatry & Clinical Neuroscience
The Journal of Forensic Psychiatry
Neuropsychopharmacology
Editorial Board:
1992-2001
2005-
Journal of Personality Disorders
Psychiatric Services
Publications:
1) Refereed journals
Published:
1.
2.
3.
4.
5.
6.
7.
8.
9.
Swartz MS, Henschen GM, Cavenar JO Jr, Hammett EB. A case of intermittent delirious
mania. American Journal of Psychiatry 1982; 139:1357-58.
Swartz MS, Cavenar JO Jr. Countertransference in expectant fathers. Psychosomatics 1984;
25:566-68.
Krishnan KR, Swartz MS, Larson MJ, Santoliquido G. Funeral mania in recurrent bipolar
disorders: Report of three cases. Journal of Clinical Psychiatry 1984; 45:310-11.
Davidson J, Swartz M, Storck M, Krishnan RR, Hammett E. A diagnostic and family study
of post-traumatic stress disorder. American Journal of Psychiatry 1985; 42:90-93.
Hargett AB, Taska RJ, Swartz M, Noll B, Fraker W. A unique nursing and milieu approach
to treating borderline patients. North Carolina Journal of Mental Health 1985; 21:35-39.
Taska RJ, Swartz MS, Hargett A, Fraker W, Noll B, Barber J. A review of borderline
disorders. North Carolina Journal of Mental Health 1986; 22:3-8.
Swartz M, Blazer D, George L, Landerman R. Somatization disorder in a community
population. American Journal of Psychiatry 1986; 143:1403-1408.
Swartz MS, McCracken J. The emergency management of conversion disorders. Hospital
and Community Psychiatry 1986; 37:828-832.
Swartz M, Blazer D, Woodbury M, George L, Landerman R. Somatization disorder in a U.S.
southern community: Use of a new procedure for analysis of medical classification.
8
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
Psychological Medicine 1986; 16:595-609.
Fraker W, Taska R, Swartz M, Hargett A, Noll B, Barber J. Working with the families of
hospitalized borderline patients. North Carolina Journal of Mental Health 1986; 22:19-25.
Swartz M, Hughes D, George L, Blazer D, Landerman R, Bucholz K. Developing a
screening index for community studies of somatization disorder. Journal of Psychiatric
Research 1986; 20:335-343.
Swartz MS. What constitutes a psychiatric emergency: Clinical and legal dimensions.
Bulletin American Academy of Psychiatry and Law 1987; 15:57-68.
Swartz MS, Hargett AB, Fraker WW, Noll BK, Taska RJ. Special clinical problems in the
management of psychiatric inpatients. Psychiatric Medicine 1987; 4:373-386.
Swartz MS, Blazer DG, Woodbury M, George LK, Manton KG. A study of somatization
disorder in a community population utilizing Grade of Membership analysis. Psychiatric
Developments 1987; 3:219-237.
Swartz M, Hughes D, Blazer D, George L. Somatization disorder in the community: A study
of diagnostic concordance in three diagnostic systems. Journal of Nervous and Mental
Disease 1987; 175:26-33.
Blazer DG, Swartz M, Woodbury M, Manton KG, Hughes D, George LK. Depressive
symptoms and depressive diagnoses in a community population: Use of a new procedure for
analysis of psychiatric classification. Archives of General Psychiatry 1988; 12:1078-1084.
Swartz MS. Malpractice liability for suicide: Clinical, legal, and rhetorical dimensions.
Psychiatric Forum 1988; 14:45-53.
Swartz M, Landerman R, Blazer D, George L. Somatization symptoms in the community: A
rural/urban comparison. Psychosomatics 1989; 30:44-53.
Swartz MS, Blazer DG, George LK, Winfield I, Zakris J, Dye E. Identification of borderline
personality disorder with the NIMH Diagnostic Interview Schedule. American Journal of
Psychiatry 1989; 146:200-205.
Melges FT, Swartz MS. Oscillations on attachment in borderline personality disorder: A
cybernetic and interpersonal model. American Journal of Psychiatry 1989; 146:1115-1120.
Jordan BK, Swartz MS, George LK, Woodbury MA, Blazer DG. Antisocial and related
disorders in a southern community: An application of Grade of Membership analysis.
Journal of Nervous and Mental Disorders 1989; 9:529-541.
Taska RJ, Hargett AB, Fraker WW, Swartz MS. Written therapeutic contracts with
borderline patients. Psychiatric Forum 1989; 14:58-60.
Escobar JI, Manu P, Matthews D, Lane T, Swartz M, Canino G. Medically unexplained
physical symptoms, somatization disorder and abridged somatization: Studies with the
Diagnostic Interview Schedule. Psychiatric Developments 1989; 7(3): 235-45.
Swartz MS, Carroll BJ, Blazer DG. In response to: Psychiatric diagnosis as reified
measurement. Journal of Health and Social Behavior 1989; 30:33-34.
Swartz MS. Legal aspects of emergent treatment refusal. Psychiatric Forum 1989; 15(1): 2835.
Winfield I, George LK, Swartz M, Blazer DG. Sexual assault and psychiatric disorders
among women in a community population. American Journal of Psychiatry 1990; 147:335341.
9
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
Swartz MS, Blazer DG, George LK. Estimating the prevalence of borderline personality
disorder in the community. Journal of Personality Disorders 1990; 4:257-272.
Turnbull JE, George LK, Landerman R, Swartz MS, Blazer DG. Social outcomes related to
age of onset among psychiatric disorders. Journal of Consulting and Clinical Psychology
1990; 58(6):832-839.
Swartz MS, Melville ML, George LK, Melville ML, Blazer D, Smith K. Benzodiazepine
anti-anxiety agents: Prevalence and correlates of use in a southern community. American
Journal of Public Health 1991; 81(5):592-596.
Greenfield SF, Swartz MS, Landerman R, George LK. The longterm psychosocial effects of
childhood exposure to parental problem drinking. American Journal of Psychiatry 1993;
150(4):608-613.
Kessler RC, McGonagle KA, Swartz MS, Blazer DG, Nelson C. Sex and depression in the
National Comorbidity Survey I: Lifetime prevalence, chronicity and recurrence. Journal of
Affective Disorders 1993; 29:85-96.
Kessler RC, McGonagle KA, Nelson CB, Hughes M, Swartz MS, Blazer DG. Sex and
depression in the National Comorbidity Survey II: Cohort effects. Journal of Affective
Disorders 1994; 30:15-26.
Blazer DG, Kessler R, McGonagle K, Swartz MS. The prevalence and distribution of major
depression in a national community sample: The National Comorbidity Survey. American
Journal of Psychiatry 1994; 151:979-986.
Swartz MS, Santos AB. Taking Issue: State purchasing cooperatives for psychotropic
medication. Hospital and Community Psychiatry 1994; 45:741.
Tweed JL, George LK, Blazer D, Swartz M, MacMillan J. Adult onset of severe and
pervasive antisocial behavior: A distinct syndrome? Journal of Personality Disorders 1994;
8(3), 192-202.
Landerman R, Burns BJ, Swartz MS, Wagner HR, George LK. The relationship between
insurance coverage and psychiatric disorder in predicting use of mental health services.
American Journal of Psychiatry 1994; 151, 1785-1790.
Swartz MS, Burns BJ, Hiday VA, George LK, Swanson J, Wagner HR. New directions in
research on involuntary outpatient commitment. Psychiatric Services 1995; 46(4), 381-385.
Borum R, Swartz M, Swanson, J. Assessing and managing violence risk in clinical practice.
Journal of Practical Psychiatry and Behavioral Health 1996; 2(4), 205-215.
Swanson J, Borum R, Swartz M, Monahan J. Psychotic symptoms and disorders and the risk
of violent behavior in the community. Criminal Behavior and Mental Health 1996; 6, 309329.
Kessler RC, Nelson CB, McGonagle KA, Liu J, Swartz M, Blazer DG. Comorbidity of
DSM-III-R major depressive disorder in the general population: Results from the U.S.
National Comorbidity Survey. British Journal of Psychiatry suppl.1997; 30:17-30.
Swartz MS, Burns BJ, George LK, Swanson J, Hiday VA, Borum R, Wagner HR. The
ethical challenges of a randomized clinical trial of involuntary outpatient commitment. The
Journal of Mental Health Administration 1997; 24, 35-43.
Swanson JW, Swartz MS, George LK, Burns BJ, Hiday VA, Borum R, Wagner HR.
Interpreting the effectiveness of involuntary outpatient commitment: A conceptual model.
10
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
53.
54.
55.
56.
57.
Journal of American Academy of Psychiatry and Law 1997; 25, 5-16.
Swanson J, Estroff S, Swartz M, Borum R, Lachicotte W, Zimmer C, Wagner R. Violence
and severe mental disorder in clinical and community populations: The effects of psychotic
symptoms, comorbidity, and lack of treatment. Psychiatry 1997; 60, 1-22.
Hiday VA, Swartz MS, Swanson JW, Wagner HR. Patient perceptions of coercion in mental
hospital admission. International Journal of Psychiatry and Law 1997; 20(2):227-241.
Borum R, Swanson JW, Swartz MS, Hiday VA. Substance abuse, violent behavior and police
encounters among persons with severe mental disorders. Journal of Contemporary Criminal
Justice 1997; 13(3):236-249.
Kessler RC, Zhao S, Blazer DG, Swartz M. Prevalence, correlates, and course of minor
depression and major depression in the national comorbidity survey. Journal of Affective
Disorders 1997; 45(1,2):19-30.
Kessler RC, Anthony JC, Blazer DG, Bromet E, Eaton WW, Kendler K, Swartz M, Wittchen
HU, Zhao S. The U.S. National Comorbidity Survey: Overview and future directions.
Epidemiogia e Psichiatria Sociale 1997; 6(1):4-16.
Swartz MS, Swanson JW, Hiday VA, Borum R, Wagner HR, Burns BJ. Violence and severe
mental illness: The effects of substance abuse and nonadherence to medication. American
Journal of Psychiatry 1998; 155(2):226-231.
Blazer DG, Kessler RC, Swartz MS. Epidemiology of recurrent major and minor depression
with a seasonal pattern: The National Comorbidity Survey. British Journal of Psychiatry
1998; 172:164-167.
Williams J, Swartz M. Treatment boundaries in the case management relationship: A clinical
case and discussion. Community Mental Health Journal 1998; 34(3): 299-311.
Swartz MS, Wagner HR, Swanson JW, Burns BJ, George LK, Padgett DK. Comparing use
of public and private mental health services: The enduring barriers of race and age.
Community Mental Health Journal 1998; 34(2): 133-143.
Hiday VA, Swartz MS, Swanson J, Borum R, Wagner HR. Male - female differences in the
setting and construction of violence among people with severe mental illness. Social
Psychiatry & Psychiatric Epidemiology 1998; 33(1): S68-S74.
Swartz MS, Swanson JW, Hiday VA, Borum R, Wagner HR, Burns BJ. Taking the wrong
drugs: The role of substance abuse and medication noncompliance and violence among
severely mentally ill individuals. Social Psychiatry & Psychiatric Epidemiology 1998;
33(1):S75-S80.
Swanson J, Swartz M, Estroff S, Borum R, Wagner R, Hiday V. Psychiatric impairment,
social contact, and violent behavior: Evidence from a study of outpatient-committed persons
with severe mental disorder. Social Psychiatry & Psychiatric Epidemiology 1998; 33(1):
S86-S94.
Estroff SE, Swanson JW, Lachicotte WS, Swartz M, Bolduc. Risk reconsidered: Targets of
violence in the social networks of people with serious psychiatric disorders. Social
Psychiatry & Psychiatric Epidemiology 1998; 33(1): S95-S101.
Swanson J, Borum R, Swartz M, Hiday V. Violent behavior preceding hospitalization among
persons with severe mental illness. Law & Human Behavior 1999; 23(2):185-204.
Borum R, Swartz M, Riley S, Swanson J, Hiday VA, Wagner R. Consumer perceptions of
11
58.
59.
60.
61.
62.
63.
64.
65.
66.
67.
68.
69.
70.
71.
72.
73.
involuntary outpatient commitment. Psychiatric Services 1999; 50(11): 1489-1491.
Swartz MS, Swanson JW, Wagner HR, Burns BJ, Hiday VA, Borum R. Can involuntary
outpatient commitment reduce hospital recidivism? Findings from a randomized trial with
severely mentally ill individuals. American Journal of Psychiatry 1999; 156 (12):1968-1975.
Swartz MS, Hiday VA, Wagner HR, Swanson JW, Borum R, Burns BJ. Measuring coercion
under involuntary outpatient commitment: Initial findings from a randomized controlled trial.
Research in Community & Mental Health 1999; 10:57-77.
Amaya-Jackson L, Davidson JR, Hughes DC, Swartz MS, George LK, Blazer DG.
Functional impairment and utilization of services associated with post-traumatic stress in the
community. Journal of Traumatic Stress 1999; 12(4):709-724.
Swanson JW, Swartz MS, Borum R, Hiday VA, Wagner HR, Burns BJ. Involuntary
outpatient commitment and reduction of violent behaviour in persons with severe mental
illness. British Journal of Psychiatry 2000; 176:324-331.
Thompson M, George LK, Swartz MS, Burns BJ, Swanson JW. Race, role responsibility and
relationship: Understanding the experience of caring for the severely mentally ill. Research in
Community & Mental Health 2000; 11:157-185.
Swanson JW, Tepper MC, Backlar P, Swartz MS. Psychiatric advance directives: An
alternative to coercive treatment? Psychiatry 2000; 63(2):160-177.
Rosenberg SD, Osher FC, Swartz M, Essock SM, Butterfield MI, Constantine N, Wolford
GL, Salyers M. Prevalence of HIV, Hepatitis B and Hepatitis C in people with severe mental
illness. American Journal of Public Health 2001; 91(1):31-37.
Swanson JW, Borum R, Swartz MS, Hiday VA, Wagner HR, Burns BJ. Can involuntary
outpatient commitment reduce arrests among persons with severe mental illness? Criminal
Justice & Human Behavior 2001; 28(2):156-189.
Swartz MS, Monahan J. Introduction: Special section on involuntary outpatient commitment.
Psychiatric Services 2001; 52(3):323-324.
Swartz MS, Swanson JW, Hiday VA, Wagner HR, Burns BJ, Borum R. A randomized
controlled trial of outpatient commitment in North Carolina. Psychiatric Services 2001;
52(3):325-329.
Steadman HJ, Gounis K, Dennis D, Hopper K, Roche B, Swartz M, Robbins PC. Assessing
the NewYork City outpatient commitment pilot program. Psychiatric Services 2001;
52(3):330-336.
Monahan J, Bonnie R, Appelbaum P, Hyde P, Steadman H, Swartz M. Mandated community
treatment: Beyond outpatient commitment. Psychiatric Services 2001; 52(8):1198-1205.
Swartz MS, Swanson JW, Wagner HR, Burns BJ, Hiday VA. Effects of involuntary
outpatient commitment and depot antipsychotics on treatment adherence in persons with
severe mental illness. Journal of Nervous & Mental Disease 2001; 189(9):583-592.
Hiday JA, Swanson JW, Swartz MS, Borum R, Wagner HR. Victimization: A link between
mental illness and violence? International Journal of Psychiatry & Law 2001; 24:559-572.
Goodman LA, Salyers MP, Mueser KT, Rosenberg SD, Swartz M, Essock SM, Osher FC,
Butterfield MI. Recent victimization in women and men with severe mental illness:
Prevalence and correlates. Journal of Traumatic Stress 2001; 14(4):615-632.
Connor KM, Davidson JRT, Hughes DC, Swartz MS, Blazer DG, George LK. The impact of
12
74.
75.
76.
77.
78.
79.
80.
81.
82.
83.
84.
85.
86.
borderline personality disorder on post-traumatic stress in the community: A study of health
status, health utilization and functioning. Comprehensive Psychiatry 2002; 43(1):41-48.
Swartz MS, Wagner HR, Swanson JW, Hiday VA, Burns BJ. The perceived coerciveness of
involuntary outpatient commitment: Findings from an experimental study. Journal of the
American Academy of Psychiatry and the Law 2002; 30(2):207-217.
Hiday VA, Swartz MS, Swanson JW, Borum R, Wagner HR. Impact of outpatient
commitment on victimization of people with severe mental illness. American Journal of
Psychiatry 2002; (159)8:1403-1411.
Swanson JW, Swartz MS, Essock SM, Osher FC, Wagner HR, Goodman LA, Rosenberg SD,
Meador KG. The socio-environmental context of violent behavior in persons with severe
mental illness. American Journal of Public Health 2002; 92(9):1523-1531.
Stroup S, Swartz M, Appelbaum P. Concealed medicines for people with schizophrenia: A
U.S. perspective. Schizophrenia Bulletin 2003; 28(3):537-542.
Compton SN, Swanson JW, Wagner HR, Swartz MS, Burns BJ, Elbogen, E. Involuntary
outpatient commitment and homelessness in persons with severe mental illness. Journal of
Mental Health Services Research 2003; 5(1), 27-38.
Swanson JW, Swartz MS, Hannon MJ, Elbogen EB, Wagner HR, McCauley BJ, Butterfield
MI. Psychiatric advance directives: A survey of persons with schizophrenia, family members,
and treatment providers. International Journal of Forensic Mental Health 2003; 2(1):73-86.
Wagner HR, Swartz MS, Swanson JW, Burns BJ. Does involuntary outpatient commitment
lead to more intensive treatment? Psychology, Public Policy and Law 2003; 9(1):145-158.
Swartz MS, Swanson JW, Monahan J. Endorsement of personal benefit of outpatient
commitment among persons with severe mental illness. Psychology, Public Policy and Law
2003; 9(1):70-93.
Rosenberg SD, Swanson JW, Wolford GL, Osher FC, Swartz MS, Essock SM, Butterfield
MI, Marsh BJ, Stover E, and the Five-Site Health & Risk Study Research Committee. The
five-site health and risk study of blood-borne infections among persons with severe mental
illness. Psychiatric Services 2003; 54(6):827-835.
Essock SM, Dowden S, Constantine NT, Katz L, Swartz MS, Meador KG, Osher FC,
Rosenberg SD, and the Five-Site Health & Risk Study Research Committee. Risk factors for
HIV, Hepatitis B, and Hepatitis C among persons with severe mental illness. Psychiatric
Services 2003; 54(6):836-841.
Osher FC, Goldberg RW, McNary SW, Swartz MS, Essock SM, Butterfield MI, Rosenberg
SD, and the Five-Site Health and Risk Study Research Committee. Substance abuse and the
transmission of Hepatitis C among persons with severe mental illness. Psychiatric Services
2003; 54(6):842-847.
Butterfield MI, Bosworth HB, Meador KG, Stechuchak KM, Essock SM, Osher FC,
Goodman LA, Swanson JW, Bastian LA, Horner RD and the Five-Site Health and Risk
Study Research Committee. Gender differences in Hepatitis C infection and risks among
persons with severe mental illness. Psychiatric Services 2003; 54(6):848-853.
Swartz MS, Swanson JW, Hannon MJ, Bosworth HS, Osher FC, Essock SM, Rosenberg SD
and the Five-Site Health and Risk Study Research Committee. Regular sources of medical
care among persons with severe mental illness at risk for Hepatitis C infection. Psychiatric
13
Services 2003; 54(6):854-859.
87. Brunette MF, Drake RE, Marsh BJ, Torrey WC, Rosenberg SD and the Five-Site Health and
Risk Study Research Committee. Responding to blood-borne infections among persons with
severe mental illness. Psychiatric Services 2003; 54(6):860-865.
88. Swartz MS, Swanson JW, Hannon MJ. Detection of illicit substance use among persons with
schizophrenia by radioimmunoassay of hair. Psychiatric Services 2003; 54(6):891-895.
89. Swartz MS, Swanson JW, Wagner HR, Hannon MJ, Burns BJ, Shumway M. Assessment of
four stakeholder groups’ preferences concerning outpatient commitment for persons with
schizophrenia. The American Journal of Psychiatry 2003; 160(6):1139-1146.
90. Stroup TS, McEvoy JP, Swartz MS, Byerly MJ, Glick ID, Canive JM, McGee MF, Simpson
GM, Stevens MC, Lieberman JA. The National Institute of Mental Health Clinical
Antipsychotic Trials of Intervention Effectiveness (CATIE) Project: Schizophrenia trial
design and protocol development. Schizophrenia Bulletin 2003; 29(1):15-31.
91. Swartz MS, Perkins DO, Stroup TS, McEvoy JP, Nieri JM, Haak DC. Assessing clinical and
functional outcomes in the Clinical Antipsychotic Trials of Intervention Effectiveness
(CATIE) schizophrenia trial. Schizophrenia Bulletin 2003; 29(1):33-43.
92. Swartz MS, Swanson JW, Hannon MJ. Does fear of coercion keep people away from mental
health treatment? Evidence from a survey of persons with schizophrenia and mental health
professionals. Behavioral Sciences and the Law 2003; 21:459-472.
93. Swanson JW, Swartz MS, Elbogen EB, Wagner HR, Burns BJ. Effects of involuntary
outpatient commitment on subjective quality of life in persons with severe mental illness.
Behavioral Sciences and the Law 2003; 21:473-491.
94. Elbogen EB, Swanson JW, Swartz MS, Wagner HR. Characteristics of third-party money
management for persons with psychiatric disabilities. Psychiatric Services 2003; 54(8):11361141.
95. Monahan J, Swartz M, Bonnie R. Mandated treatment in the community for people with
mental disorders. Health Affairs 2003; 22(5):28-38.
96. Elbogen E, Swanson JW, Swartz MS. Effects of legal mechanisms on perceived coercion and
treatment adherence among persons with severe mental illness. Journal of Nervous and
Mental Disease 2003; 191:10, 629-637.
97. Elbogen EB, Swanson JW, Swartz MS. Psychiatric disability, the use of financial leverage,
and perceived coercion in mental health services. International Journal of Forensic Mental
Health 2003; 2(2):119-127.
98. Swartz M, Morrissey J. Mental health care in North Carolina: Challenges on the road to
reform. NC Medical Journal 2003; 64(5):205-211.
99. Butterfield MI, Bosworth HB, Stechuchak KM, Frothingham R, Bastian LA, Meador KG,
Swartz M, Horner RD. Racial differences in Hepatitis B and Hepatitis C and associated risk
behaviors in veterans with severe mental illness. Journal of the National Medical Association
2004; 96:1, 43-52.
100. Swanson JW, Swartz, MS, Elbogen E. Effectiveness of atypical antipsychotic medications in
reducing violent behavior among persons with schizophrenia in community-based treatment.
Schizophrenia Bulletin 2004; 30 (1):3-20.
101. Mueser KT, Salyers MP, Rosenberg SD, Goodman LB, Essock SM, Osher FC, Swartz MS,
14
102.
103.
104.
105.
106.
107.
108.
109.
110.
111.
112.
113.
114.
115.
Butterfield M. & 5 Site Health & Risk Study Research Committee. Interpersonal trauma and
posttraumatic stress disorder in patients with severe mental illness: Demographic, clinical and
health correlates. Schizophrenia Bulletin 2004; 30(1):45-57.
Swartz MS, Wagner HR, Swanson JW, Elbogen EB. Consumers’ perceptions of the fairness
and effectiveness of mandated community treatment and related treatment pressures.
Psychiatric Services 2004; 55(7):780-785.
Groff A, Burns BJ, Swanson JW, Wagner HR, Tompson, M. Caregiver strain among persons
with severe mental illness under involuntary outpatient commitment. Journal of Nervous and
Mental Disease 2004; 192(8):554-562.
Swartz MS, Swanson JW. Involuntary outpatient commitment, community treatment orders,
and assisted outpatient treatment: What’s in the data? Canadian Journal of Psychiatry 2004;
49(9):585-591.
Swartz MS, Swanson JW, Elbogen EB. Psychiatric advance directives: Practical, legal and
ethical issues. Journal of Forensic Psychology Practice 2004; 4(4):97-107.
Swanson JW, Swartz MS, Elbogen EB, Van Dorn RA. Reducing violence risk in persons
with schizophrenia: Olanzapine versus risperidone. The Journal of Clinical Psychiatry 2004;
65(12):1666-1673.
HIV/AIDS Treatment Adherence, Health Outcomes and Cost Study Group (Swartz MS, CoPI). The HIV/AIDS treatment adherence, health outcomes and cost study: Conceptual
foundations and overview. AIDS Care 2004; 16 (Supp 1): S6-S21.
Monahan J, Redlich AD, Swanson J, Robbins PC, Appelbaum PS, Petrila J, Steadman HJ,
Swartz M, Angell B, McNiel DE. Use of leverage to improve adherence to psychiatric
treatment in the community. Psychiatric Services 2005, 56(1):37-44.
Elbogen E, Soriano C, Van Dorn R, Swartz MS, Swanson JW. Consumer views of
representative payee use of disability funds to leverage treatment adherence. Psychiatric
Services 2005; 56(1):45-49.
Whetten K, Reif S, Napravnik S, Swartz MS, Thielman NM, Eron JJ, Lowe K, Soto T.
Substance abuse and symptoms of mental illness among HIV positive persons in the
Southeast. Southern Medical Journal 2005, 98(1):9-14.
Whetten K, Reif S, Swartz M, Stevens R, Ostermann J, Hanisch L, Eron JJ. A brief mental
health and substance abuse screener for persons with HIV. AIDS Patient Care and Studies
2005, 19(2):89-99.
Leserman J, Whetten K, Lowe K, Stangl D, Swartz M, Thielman NM. How trauma, recent
stressful events and PTSD affect functional health status and health utilization in HIVinfected patients in the south. Psychosomatic Medicine 2005; 67:500-507.
Van Dorn RA, Swanson JW, Swartz MS, Elbogen EB. The effects of race and criminal
justice involvement on access to atypical antipsychotic medications among persons with
schizophrenia. Mental Health Services Research 2005; 7(2):123-134.
Slade EP, Salkever DS, Rosenheck R, Swanson J, Swartz M, Shern D, Gallucci G, Harding
C, Palmer L, Russo PA. Cost-sharing and access to mental health care among Medicare
enrollees with schizophrenia. Psychiatric Services 2005; 56(8):960-966.
Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RSE,
Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK. Effectiveness of antipsychotic drugs
15
116.
117.
118.
119.
120.
121.
122.
123.
124.
125.
126.
127.
128.
129.
in patients with chronic schizophrenia. The New England Journal of Medicine 2005;
353(12):1209-1223.
Elbogen EB, Swanson JW, Swartz MS, Van Dorn R. Medication nonadherence and
substance abuse in psychotic disorders: Impact of depressive symptoms and social stability.
The Journal of Nervous and Mental Disease 2005; 193(10):673-679.
Van Dorn RA, Swanson JW, Elbogen EB, Swartz MS. A comparison of stigmatizing
attitudes toward persons with schizophrenia in four stakeholder groups: Perceived likelihood
of violence and desire for social distance. Psychiatry 2005; 68(2):152-163.
Swartz MS, Swanson JW, Ferron J, Elbogen EB, Van Dorn R, Kim M, Scheyett A.
Psychiatrists’ views and attitudes about psychiatric advance directives. International
Association of Forensic Mental Health Services 2005; 4(2):107-117.
Van Dorn RA, Swartz MS, Swanson JW, Elbogen EB. Perceived fairness and effectiveness
of leveraged community treatment among public mental health consumers in five U.S. cities.
International Association of Forensic Mental Health Services 2005; 4(2):119-133.
Van Dorn RA, Mustillo S, Elbogen EB, Dorsey S, Swanson JW, Swartz MS. The effects of
early sexual abuse on adult risky sexual behaviors among persons with severe mental illness.
Child Abuse and Neglect 2005; 29(11);1265-1279.
Elbogen EE, Swanson JW, Swartz MS, Van Dorn R. Family representative payeeship and
violence risk in severe mental illness. Law and Human Behavior 2005; 29:563-574.
Rosenheck RA, Stroup S, Keefe R, McEvoy J, Swartz M, Perkins D, Hsaio J, Shumway M,
Lieberman J. Measuring outcome priorities and incorporating preferences in mental health
status assessment of people with schizophrenia. British Journal of Psychiatry 2005; 187:529536.
Miller DD, McEvoy JP, Davis S, Caaroff SN, Saltz, BL, Chakos MH, Swartz M, Keefe R,
Rosenheck R, Stroup S, Lieberman JA. Clinical correlates of tardive dyskinesia in
schizophrenia: Baseline data from the CATIE schizophrenia trial. Schizophrenia Research
2005; 80:33-43.
Stroup S, Appelbaum P, Swartz M, Patel M, Davis S, Jeste D, Kim S, Manschreck T,
McEvoy J, Lieberman J. Decision-making capacity for research participation among
individuals in the CATIE schizophrenia trial. Schizophrenia Research 2005, 80:1-8.
Davidson JRT, Connor KM, Swartz M. Mental illness in U.S. presidents between 17761974.; A review of biographical sources. The Journal of Nervous and Mental Disease 2006;
194(1): 47-51.
Rosenheck R, Leslie D, Keefe R, McEvoy J, Swartz M, Perkins D, Stroup S, Hsaio J,
Lieberman J. Barriers to employment for people with schizophrenia. The American Journal
of Psychiatry 2006; 163(3):411-417.
Elbogen EB, Swartz MS, Van Dorn R, Swanson JW, Kim M, Scheyett A. Clinician decisionmaking and attitudes on implementing psychiatric advance directives. Psychiatric Services,
2006; 57(3):350-355.
Swartz MS, Swanson J, Kim M, Petrila J. Use of outpatient commitment and similar civil
court treatment orders in five United States communities. Psychiatric Services 2006;
57(3):343-349.
Ascher-Svanum H, Faries D, Ernst F, Zhu B, Ernst F, Swartz M, Swanson J. Medication
16
130.
131.
132.
133.
134.
135.
136.
137.
138.
139.
140.
141.
adherence and long-term functional outcomes in the treatment of schizophrenia in usual care.
Journal of Clinical Psychiatry 2006; 67(3):453-460.
Ascher-Svanum H, Zhu B, Faries DE, Tunis S, Landbloom RP, Swartz M, Swanson J. Time
to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of
schizophrenia. BioMedCentral Psychiatry, 2006; 6:8.
McEvoy JP, Lieberman JA, Stroup TS, Davis SM, Rosenheck RA, Swartz MS, Perkins DO,
Keefe RSE, Davis CE, Severe J, Hsiao JK for CATIE Investigators. Effectiveness of
clozapine versus olanzapine, quetiapine and risperidone in patients with chronic
schizophrenia who failed prior atypical antipsychotic treatment. American Journal of
Psychiatry 2006; 153:600-610.
Stroup TS, Lieberman JA, McEvoy JP, Swartz MS, Davis SM, Rosenheck RA, Perkins DO,
Keefe RSE, Davis CE, Severe J, Hsiao JK for the CATIE Investigators. Effectiveness of
olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia
after discontinuation of a previous atypical antipsychotic. American Journal of Psychiatry
2006; 163:611-622.
Swanson JW, Swartz MS, Ferron J, Elbogen EB, Van Dorn RA. Psychiatric advance
directives among public mental health consumers in five United States cities: Prevalence,
demand, and correlates. Journal of American Academy of Psychiatry and the Law 2006;
34:43-57.
Whetten K, Leserman J, Whetten R, Ostermann J, Thielman N, Swartz M, Stangl D.
Exploring lack of trust in care providers and the government as a barrier to health service use.
American Journal of Public Health 2006; 96(4):1-6.
Swartz MS, Wagner HR, Swanson JW, Stroup TS, McEvoy JP, Canive JM, Miller DD,
Reimherr F, McGee M, Khan A, Van Dorn R, Rosenheck RA, Lieberman JA. Substance use
in persons with schizophrenia: Baseline prevalence and correlates from the NIMH CATIE
study. The Journal of Nervous and Mental Disease 2006; 194:164-172.
Swanson JW, Swartz MS, Van Dorn RA, Elbogen EB, Wagner HR, Rosenheck RA, Stroup
TS, McEvoy JP, Lieberman JA. A national study of violent behavior in persons with
schizophrenia. Archives of General Psychiatry 2006; 63:490-499.
Swartz MS, Swanson JW, Van Dorn RA, Elbogen EB, Shumway M. Patient Preferences for
Psychiatric Advance Directives. International Journal of Forensic Mental Health 2006; 5:6781.
Swanson JW, McCrary SV, Swartz MS, Elbogen EB. Overriding psychiatric advance
directives: Factors associated with psychiatrists’ decisions to preempt patients’ advance
refusal of hospitalization and medication. Law and Human Behavior 2006; 1-14.
Strauss JL, Calhoun PS, Marx CE, Stechuchak KM, Oddone EZ, Swartz M, Butterfield MI.
Comorbid posttraumatic stress disorder is associated with suicidality in male veterans with
schizophrenia or schizoaffective disorder. Schizophrenia Research, 2006; 84:165-169.
Van Dorn RA, Swartz MS, Elbogen EB, Swanson JW, Kim M, Ferron J, McDaniel LA,
Scheyett AM. Clinicians’ attitudes regarding barriers to the implementation of psychiatric
advance directives. Administration & Policy in Mental Health & Mental Health Services
Research 2006; 33(4):449-460.
Swanson JW, Van Dorn RA, Monohan J, Swartz MS. Violence and leveraged community
17
142.
143.
144.
145.
146.
147.
148.
149.
150.
151.
152.
153.
154.
treatment for persons with mental disorders. American Journal of Psychiatry 2006;
163(8):1404-1411.
Rosenheck R, Swartz MS, Lieberman JA. Practical clinical trials in psychiatry: Studies of
schizophrenia from the CATIE Network. Psychiatric Services 2006; 57:1093.
Swartz MS, Wagner HR, Swanson JW, Stroup TS, McEvoy JP, McGee M, Miller DD,
Reimherr F, Khan A, Canive JM, Lieberman JA. Substance use and psychosocial functioning
in schizophrenia among new enrollees in the NIMH CATIE Study. Psychiatric Services 2006;
57:1110-1116.
Chwastiak LA, Rosenheck R, McEvoy J, Keefe RS, Swartz M, Lieberman JA.
Interrelationships of psychiatric symptom severity, medical comorbidity and functioning in
schizophrenia. Psychiatric Services 2006; 57:1102-1109.
Perlick DA, Rosenbeck RA, Zaczynski R, Swartz MS, Canive JM, Lieberman JA.
Components and correlates of family burden in schizophrenia. Psychiatric Services 2006;
57:1117-1125.
Keefe RSE, Bilder RM, Harvey PD, Davis S, Palmer BW, Gold JM, Meltzer HY, Green MF,
Miller DD, Canive JM, Adler LW, Manschreck T, Swartz M, Rosenheck R, Perkins DO,
Walker TM, Stroup TS, McEvoy JP, Lieberman JA. Baseline neurocognitive deficits in the
CATIE Schizophrenia Trial. Neuropsychopharmacology, 2006; 4:1-14.
Whetten K, Reif S, Ostermann J, Pence BW, Swartz M, Whetten R, Conover C, Bouis S,
Theilman N, Eron J. Improving health outcomes among individuals with HIV, mental illness,
and substance use disorders in the Southeast. AIDS Care 2006; 18(1):18-26.
Mugavero M, Ostermann J, Whetten K, Leserman J, Swartz M, Stangl D, Thielman N.
Barriers to antiretroviral adherence: The importance of physical abuse, sexual abuse and
other traumatic events. AIDS Patient Care and STDs 2006; 20(6):418-428.
Whetten K, Leserman J, Lowe K, Stangl D, Thielman N, Swartz M, Hanisch L, Van Scoyoc
L. Prevalence of childhood sexual abuse and physical trauma in an HIV-positive sample from
the deep south. American Journal of Public Health 2006; 96(6):1028-1030.
Elbogen EB, Van Dorn RA, Swanson JW, Swartz MS, Monahan J. Treatment engagement
and violence risk in mental disorders. British Journal of Psychiatry 2006; 189:354-360.
Swanson JW, McCrary SV, Swartz MS, Elbogen EB, Van Dorn RA. Superseding psychiatric
advance Directives: Ethical & legal considerations. Journal of the American Academy of
Psychiatry and the Law 2006; 34:385-394.
Swanson JW, Swartz MS, Elbogen EB, Van Dorn RA, Ferron J, Wagner HR, McCauley BJ,
Kim M. Facilitated psychiatric advance directives: A randomized trial of an intervention to
foster advance treatment planning among persons with severe mental illness. American
Journal of Psychiatry 2006; 163:1943-1951.
Van Dorn RA, Elbogen EB, Redlich AD, Swanson JW, Swartz MS, Mustillo S. The
relationship between mandated treatment and perceived barriers to care in persons with
severe mental illness. International Journal of Law & Psychiatry 2006; 29:495-506.
Rosenheck R, Leslie D, Sindelar J, Miller EA, Stroup S, McEvoy J, Davis S, Davis CE,
Keefe RSE, Swartz M, Perkins D, Hsiao JK, Lieberman J. for the CATIE Study Investigators.
Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized
trial of treatment for chronic schizophrenia. American Journal of Psychiatry 2006;
18
155.
156.
157.
158.
159.
160.
161.
162.
163.
164.
165.
166.
163(12):2080-2089.
Elbogen EB, Mustillo S, Van Dorn R, Swanson JW, Swartz MS. Treatment engagement and
violence risk in mental disorders. British Journal of Psychiatry 2006; 189:354-360.
Elbogen EB, Mustillo S, Van Dorn R, Swanson JW, Swartz MS. The impact of perceived
need for treatment on risk of arrest and violence among people with severe mental illness.
Criminal Justice and Behavior 2007; 34:197-210.
Stroup TS, Lieberman JA, McEvoy JP, Swartz MS, Davis SM, Capuano G, Rosenheck RA,
Keefe RSE, Miller A, Belz I, Hsiao JK for the CATIE Investigators. Effectiveness of
olanzapine, ouetiapine, and risperidone in patients with chronic schizophrenia after
discontinuing perphenazine: A CATIE Study. American Journal of Psychiatry 2007; 164
(3):415-427.
Swartz MS, Perkins DO, Stroup TS, Davis SM, Capuano G, Rosenheck RA, Reimherr F,
McGee MF, Keefe RSE, McEvoy JP, Hsiao JK, Lieberman JA for the CATIE Investigators.
Effects of antipsychotic medications on psychosocial functioning in patients with chronic
schizophrenia: Findings from the NIMH CATIE Study. American Journal of Psychiatry 2007;
164 (3): 428-436.
Elbogen EB, Swanson JW, Appelbaum P, Swartz MS, Ferron J, Van Dorn RA, Wagner HR.
Competence to complete psychiatric advance directives: Effects of facilitated decision
making. Law and Human Behavior 2007; 31(3):275-289.
Salkever DS, Karakus MC, Slade EP, Harding CM, Hough RL, Rosenheck RA, Swartz MS,
Barrio C, Yamada AM. Measures and predictors of community-based employment and
earnings of persons with schizophrenia in a multisite study. Psychiatric Services 2007;
58(3):315-324.
Rosenheck R, Swartz M, McEvoy J, Stroup TS, Davis S, Keefe R, Hsiao J, Lieberman J.
Second generation antipsychotics: Reviewing the cost-effectiveness component of the CATIE
trial. Expert Review of Pharmacoeconomics & Outcomes Research 2007; 7(2):103-111.
Keefe RSE, Bilder RM, Harvey PD, Davis SM, Palmer B, Gold JM, Meltzer HY, Green MF,
Capuno G, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Davis CE,
Hsiao JK, Lieberman JA, for the CATIE Investigators and the Neurocognitive Working
Group. Neurocognitive effects of antipsychotic medications in patients with chronic
schizophrenia in the CATIE Trial. Archives of General Psychiatry 2007; 64: 633-647.
Kim MM, Van Dorn RA, Scheyett AM, Elbogen EE, Swanson JW, Swartz MS, McDaniel
LA. Understanding the personal and clinical utility of Psychiatric Advance Directives: A
qualitative perspective. Psychiatry: Interpersonal and Biological Processes 2007; 70:19-29.
Kim MM, Swanson, JW, Swartz MS, Bradford DW, Mustillo SA, Elbogen EB and the FiveSite Health and Risk Study Research Committee. Healthcare barriers among severely
mentally ill homeless adults: Evidence from the Five-Site Health and Risk Study.
Administration and Policy in Mental Health Mental Health Services Research 2007; 34: 363375.
Swanson JW, Van Dorn RA, Swartz MS. Effectiveness of atypical antipsychotics for
reducing substance use in schizophrenia patients. Schizophrenia Research 2007; 94:114-118.
Scheyett A, Kim M, Swanson J, Swartz M. Psychiatric advance directives: A tool for
consumer empowerment and recovery. Psychiatric Rehabilitation Journal 2007; 31(1):70-75.
19
167. Swanson JW, McCrary VS, Swartz MS, Van Dorn RA, Elbogen EB. Overriding psychiatric
advance directives: Factors associated with psychiatrists’ decisions to preempt patients’
advance refusal of hospitalization and medication. Law & Human Behavior 2007; 31(1):7790.
168. Swartz MS, Swanson JW. Commentary: Psychiatric advance directives and recoveryoriented care. Psychiatric Services 2007; 58(9):1164.
169. Swartz M. Taking Issue: Can mandated outpatient treatment prevent tragedies? Psychiatric
Services 2007; 58(6): 737.
170. Wilder CM, Elbogen EB, Swartz MS, Swanson JW, Van Dorn RA. Effect of patients’
reasons for refusing treatment on implementing Psychiatric Advance Directives. Psychiatric
Services 2007; 58(10):1348-1350.
171. Mugavero MJ, Pence BW, Whetten K, Leserman J, Swartz M, Stangl D, Thielman NM.
Predictors of AIDS-related morbidity and mortality in a southern U.S. cohort. AIDS Patient
Care and STDs 2007; 21 (9):681-690.
172. Leserman J, Pence BW, Whetten K, Mugavero MJ, Thielman NM, Swartz MS, Stangl D.
Relation of lifetime trauma and depressive symptoms to mortality in HIV. American Journal
of Psychiatry 2007; 164 (11):1707-1713.
173. Pence BW, Reif S, Whetten K, Leserman J, Stangl D, Swartz M, Thielman N, Mugavero MJ.
Minorities, the poor and survivors of abuse: HIV-infected patients in the U.S. deep South.
Southern Medical Journal 2007; 100(11): 1114-1122.
174. Zervakis JB, Stechuchak KM, Olsen MK, Swanson J, Oddone EZ, Weinberger M, Bryce ER,
Butterfield MI, Swartz MS, Straus JL. Previous involuntary commitment is associated with
current perceptions of coercion in voluntarily hospitalized patients. International Journal of
Forensic Mental Health 2007; 6(2):105-112.
175. Elbogen EB, Ferron J, Swartz MS, Wilder C, Swanson JW, Wagner HR. Characteristics of
representative payeeship involving families of beneficiaries with psychiatric disabilities.
Psychiatric Services 2007; 58(11):1433-1440.
176. Mugavero MJ, Pence BW, Whetten K, Leserman J, Swartz M, Stangl D, Thielman NM.
Childhood abuse and initial presentation for HIV care: An opportunity for early intervention.
AIDS Care 2007; 19(9):1083-1087.
177. Bouis S, Reif S, Whetten K, Scovil J, Murray A, Swartz M. An integrated multidimensional
treatment model for individuals living with HIV, mental illness, and substance abuse. Health
and Social Work 2007; 32(4):268-278.
178. Stroup TS, McEvoy JP, Swartz MS, Hamer RM, Perkins DO, Lieberman JA. Comparison of
antipsychotics for metabolic problems (CAMP): A NIMH schizophrenia trials network study.
Clinical Schizophrenia and Related Psychoses 2007; 1(1):69-72.
179. Swartz MS, Wagner HR, Swanson JW, Stroup TS, McEvoy JP, Reimherr F, Miller DD,
McGee M, Khan A, Canive JM, Davis SM, Hsiao JK, Lieberman JA for the CATIE
Investigators. The effectiveness of antipsychotic medications in patients who use or avoid
illicit substances: Results from the CATIE Study. Schizophrenia Research 2008; 100:39-52.
180. Resnick SG, Rosenheck RA, Canive J, DeSouza C, Stroup TS, McEvoy J, Davis S, Keefe
RSE, Swartz M, Lieberman J for the CATIE Investigators. Employment outcomes in a
randomized trial of second-generation antipsychotics and perphenazine in the treatment of
20
181.
182.
183.
184.
185.
186.
187.
188.
189.
190.
191.
192.
193.
194.
individuals with schizophrenia. The Journal of Behavioral Health Services and Research
2008; 35(2):215-225.
Scheyett A, Kim M, Swanson J, Swartz M, Elbogen E, Van Dorn R, Ferron J. Social
workers’ familiarity with psychiatric advance directives: Implications for education, practice,
and research. Families in Society: The Journal of Contemporary Social Services 2008;
89(2):228-236.
Swartz MS, Swanson JW. Outpatient commitment: When it improves patient outcomes.
Current Psychiatry 2008; 7(4): 25-35.
Swartz MS. Introduction to the CATIE Special Section. Psychiatric Services 2008;
59(5):497-499.
Swartz MS, Stroup TS, McEvoy JP, Davis SM, Rosenheck RA, Keefe RSE, Hsiao JK,
Lieberman JA for the CATIE Investigators. What CATIE Found: Results from the NIMH
Schizophrenia Trial. Psychiatric Services 2008; 59(5):500-506.
Domino ME, Swartz MS. Who are the new users of antipsychotic medications? Psychiatric
Services 2008; 59(5):507-514.
Elbogen EB, Swanson JW, Swartz MS, Van Dorn R, Ferron J, Wagner HR, Wilder C.
Effectively implementing psychiatric advance directives to promote self-determination of
treatment among people with mental illness. Psychology, Public Policy, and Law 2008;
13(4):273-288.
Elbogen EB, Wilder C, Swartz MS, Swanson JW. Caregivers as money managers for adults
with severe mental illness: How treatment providers can help. Academic Psychiatry 2008;
32(2):104-110.
Kim MM, Van Dorn RA, Scheyett AM, McDaniel LA, Elbogen EB, Swartz MS, Swanson
JW, Ferron J. Front line workers’ attitudes towards psychiatric advance directives.
Community Mental Health Journal 2008; 44:28-46.
Elbogen EB, Beckham JC, Butterfield MI, Swartz M, Swanson J. Assessing risk of violent
behavior among veterans with severe mental illness. Journal of Traumatic Stress 2008; 21(1):
113-117.
Mohamed S, Rosenheck R, Swartz M, Stroup S, Lieberman JA, Keefe RSE. Relationship of
cognition and psychopathology to functional impairment in schizophrenia. American Journal
of Psychiatry 2008; 165:978-987.
Swanson JW, Swartz MS, Elbogen EB, Van Dorn RA, Wagner HR, Moser LA, Wilder C,
Gilbert AR. Psychiatric advance directives and reduction of coercive crisis interventions.
Journal of Mental Health 2008; 17(3):255-267.
Wolford G, Rosenberg S, Rosenberg H, Swartz M, Butterfield M, Swanson J, Jankowski K.
A clinical trial comparing interviewer versus computer-assisted assessment among clients
with severe mental illness. Psychiatric Services 2008; 59(7): 769-775.
Swanson JW, Swartz MS, Van Dorn RA, Volavka J, Monahan J, Stroup TS, McEvoy JP,
Wagner HR, Elbogen EB, Lieberman JA for the CATIE Investigators. Comparison of
antipsychotic medication effects on reducing violence in persons with chronic schizophrenia.
The British Journal of Psychiatry 2008; 193:37-43.
Swanson JW, Van Dorn RA, Swartz MS, Smith A, Elbogen E, Monahan J. Alternative
pathways to violence in persons with schizophrenia: The role of childhood antisocial
21
behavior problems. Law & Human Behavior 2008; 32:228-240.
195. Van Dorn R, Swanson JW, Swartz MS, Elbogen E, Ferron J. Reducing barriers to completing
psychiatric advance directives. Administration & Policy in Mental Health Services & Mental
Health Services Research 2008; on line: DOI 10.1007/s10488-008-0187-6
196. Miller DD, Caroff SN, Davis SM, Rosenheck RA, McEvoy JP, Saltz BL, Riggio S, Chakos
MH, Swartz MS, Keefe RSE, Stroup TS, Lieberman JA for the Clinical Antipsychotic Trials
of Intervention Effectiveness (CATIE) Investigators. Extrapyramidal side effects of
antipsychotics in a randomized trial: Findings from the CATIE Schizophrenia Trial. The
British Journal of Psychiatry 2008; 193:279-288.
197. Meyer JM, Davis VG, McEvoy JP, Goff DC, Nasrallah HA, Davis SM, Daumit GL, Hsiao J,
Swartz MS, Stroup TS, Lieberman JA. Impact of antipsychotic treatment on nonfasting
triglycerides in the CATIE Schizophrenia Trial phase I. Schizophrenia Research 2008;
103:104-109.
198. Meyer JM, Davis VG, Goff DC, McEvoy JP, Nasrallah HA, Davis SM, Rosenheck RA,
Daumit GL, Hsiao J, Swartz MS, Stroup TS, Lieberman JA. Change in metabolic syndrome
parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: Prospective data
from phase I. Schizophrenia Research 2008; 101:273-286.
199. Chong SA, Subramaniam M, Deurenberg-Yap M, Verma S, Swartz M. Performance measures
for mental health care in Singapore. Annals Academy of Medicine Singapore 2008;
37(9):791-796.
200. Stroup TS, Lieberman JA, McEvoy JP, Davis SM, Swartz MS, Keefe RS, Miller AL,
Rosenheck RA, Hsiao JK for the CATIE Investigators. Results of phase 3 of the CATIE
schizophrenia trial. Schizophrenia Research 2009; 107:1-12.
201. Chwastiak LA, Rosenheck RA, McEvoy JP, Stroup TS, Swartz MS, Davis SM, Lieberman
JA. The impact of obesity on health care costs among persons with schizophrenia. General
Hospital Psychiatry 2009; 31(1):1-7.
202. Rosenheck RA, Davis S, Covell N, Essock S, Swartz M, Stroup S, McEvoy J, Lieberman J.
Does switching to a new antipsychotic improve outcomes? Data from the CATIE Trial.
Schizophrenia Research 2009; 107(1):22-29.
203. Mohamed S, Rosenheck R, McEvoy J, Swartz M, Stroup, Lieberman JA. Cross-sectional and
longitudinal relationships between insight and attitudes toward medication and clinical
outcomes in chronic schizophrenia. Schizophrenia Bulletin 2009; 35(2):336-346.
204. Scheyett A, Kim M, Swanson J, Swartz M, Elbogen E, Van Dorn R, Ferron J. Autonomy and
the use of directive intervention in the treatment of individuals with serious mental illnesses:
A survey of social work practitioners. Social Work in Mental Health 2009; 7(4):283-306.
205. Swanson J, Swartz M, Van Dorn R, Monahan J, McGuire TG, Steadman HJ, Robbins PC.
Racial disparities in involuntary outpatient commitment: Are they real? Health Affairs 2009;
28(3):816-826.
206. Rosenheck RA, Davis VG, Davis SM, Stroup S, McEvoy J, Swartz M, Lieberman J. Can a
nonequivalent choice of dosing regimen bias the results of flexible dose double blind trials?
The CATIE schizophrenia trial. Schizophrenia Research 2009; 113:12-18.
207. Van Dorn R, Swanson JW, Swartz MS. Preferences for Psychiatric Advance Directives
among Latinos: Views on advance care planning for mental health. Psychiatric Services
22
2009; 60(10):1383-1385.
208. Meyer JM, McEvoy JP, Davis VG, Goff DC, Nasrallah HA, Davis SM, Hsiao JK, Swartz MS,
Stroup TS, Lieberman JA. Inflammatory markers in schizophrenia: Comparing antipsychotic
effects in phase 1 of the clinical antipsychotic effectiveness study. Biological Psychiatry
2009; 66(11):1013-1022.
209. Perlick DA, Rosenheck RA, Kaczynski R, Swartz MS, Canive JM, Lieberman JA. Impact of
antipsychotic medication on family burden in schizophrenia: Longitudinal results of the
CATIE Trial. Schizophrenia Research 2010; 116(2-3):118-125.
210. Van Dorn RA, Scheyett A, Swanson JW, Swartz MS. Psychiatric advance directives and
social workers: An integrative review. Social Work 2010; 55(2); 157-167.
211. Wilder CM, Elbogen EB, Moser LL, Swanson JW, Swartz MS. Medication preferences and
adherence among individuals with severe mental illness and Psychiatric Advance Directives.
Psychiatric Services 2010; 61(4):380-385.
212. Swartz MS. Taking Issue: Advancing research at the intersection of the mental health and
criminal justice systems. Psychiatric Services 2010; 61:431.
213. Swartz MS. Introduction to the Special Section on assisted outpatient treatment in New York
State. Psychiatric Services 2010; 61(10):967-969.
214. Robbins PC, Keator KJ, Steadman HJ, Swanson JW, Wilder CM, Swartz MS. Regional
differences in New York’s Assisted Outpatient Treatment Program. Psychiatric Services
2010; 61(10): 970-975.
215. Swartz MS, Wilder CM, Swanson JW, Van Dorn RA, Robbins PC, Steadman HJ, Moser LL,
Gilbert AR, Monahan J. Assessing outcomes for consumers in New York’s Assisted
Outpatient Treatment Program. Psychiatric Services 2010; 61(10):976-981.
216. Van Dorn RA, Swanson JW, Swartz MS, Wilder CM, Moser LL, Gilbert AR, Robbins PC,
Steadman HJ. Continuing medication and hospitalization outcomes after assisted outpatient
treatment in New York. Psychiatric Services 2010; 61(10):982-987.
217. Swanson JW, Van Dorn RA, Swartz MS, Cislo AS, Wilder CM, Moser LL, Gilbert AR,
McGuire TG. Robbing Peter to Pay Paul: Did New York State’s involuntary outpatient
commitment program crowd out voluntary service recipients? Psychiatric Services 2010;
61(10):988-995.
218. Gilbert AR, Moser LL, Van Dorn RA, Swanson JW, Wilder CM, Robbins PC, Keator KJ,
Steadman HJ, Swartz MS. Reductions in arrest under assisted outpatient treatment in New
York. Psychiatric Services 2010; 61(10):996-999.
219. Busch AB, Wilder CM, Van Dorn RA, Swartz MS, Swanson JW. Changes in guidelinerecommended medication possession after implementing Kendra’s Law in New York.
Psychiatric Services 2010; 61(10):1000-1005.
220. Caroff SN, Davis VG, Miller DD, Davis SM, Rosenheck RA, McEvoy JP, Campbell C, Saltz
BL, Riggio S, Chakos MH, Swartz MS, Keefe ESE, Stroup TS, Lieberman JA for the CATIE
investigators. Treatment outcomes of patients with tardive dyskinesia in the CATIE
schizophrenia trial. Journal of Clinical Psychiatry 2011; 72(3):295-303.
221. Addington D, Mohamed S, Rosenheck RA, Stroup TS, McEvoy J, Swartz M, Lieberman J.
Impact of second generation antipsychotics and perphenazine on depressive symptoms in a
randomized trial of treatment for chronic schizophrenia. Journal of Clinical Psychiatry 2011;
23
222.
223.
224.
225.
226.
227.
228.
229.
230.
231.
232.
233.
234.
72(1):75-80.
Ferron JC, Elbogen EB, Swanson JW, Swartz MS, McHugo GJ. A conceptually based scale
to measure consumers’ treatment motivation. Research on Social Work Practice 2011;
21(1):98-105.
Hermes E, Nasrallah H, Davis V, Meyer J, McEvoy J, Goff D, Davis S, Stroup TS, Swartz
M, Lieberman J, Rosenheck R. The association between weight change and symptom
reduction in the CATIE schizophrenia trial. Schizophrenia Research 2011; 128(1-3):166-170.
Stroup TS, Appelbaum, Gu H, Hays S, Swartz MS, Keefe RSE, Kim S, Manschreck T,
Boshes R, McEvoy JP, Lieberman JA. Longitudinal consent-related abilities among research
participants with schizophrenia: Results from the CATIE study. Schizophrenia Research,
2011 (on line); doi:10.1016/j.schres.2011.04.012.
Benjamin D, Swartz M, Forman L. The impact of evidence-based education on prescribing in
a psychiatry residency. Journal of Psychiatric Practice 2011; 17(2):110-117.
Stroup TS, McEvoy JP, Ring KD, Hamer RH, LaVange LM, Swartz MS, Rosenheck RA,
Perkins DO, Nussbaum AM, Lieberman JA. Comparison of antipsychotics for metabolic
problems (CAMP): A randomized trial examining the effectiveness of switching from
olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk. American
Journal of Psychiatry 2011; 168:947-956.
Stroup TS, Appelbaum PS, Gu H, Hays S, Swartz MS, Keefe RS, Kim SY, Manschreck TC,
Boshes RA, McEvoy JP, Lieberman JA. Longitudinal consent-related abilities among
research participants with schizophrenia: Results from the CATIE study. Schizophrenia
Research 2011; 130:47-52.
Greenberg G, Rosenheck RA, Erickson S, Desai RA, Stefanovics E, Swartz M, Keefe RS,
McEvoy J, Stroup TS. Criminal justice system involvement among people with
schizophrenia. Community Mental Health Journal 2011; 47(6):727-736.
Kerfoot KE, Rosenheck RA, Petrakis IL, Swartz MS, Keefe RSE, McEvoy JP, Stroup TS for
the CATIE Investigators. Substance use and schizophrenia: Adverse correlates in the CATIE
study sample. Schizophrenia Research 2011; 132:177-182.
Swartz MS. Taking Issue: Storm clouds over the public mental health safety net. Psychiatric
Services 2011; 62(8): 821. ps.psychiatryonline.org
Wu LT, Swartz MS, Wu Z, Mannelli P, Yang C, Blazer DG. Alcohol & drug use among
adults in emergency department settings in the United States. Annals of Emergency Medicine
2012; 60(2), 172-180.
Swartz, MS, Morrissey J. Public Behavioral Health Care Reform in North Carolina: Will We
Get It Right This Time Around? N.C. Medical Journal 2012; 73(3):177-184.
Van Dorn RA, Desmarais SL, Young MS, Sellers BG, Swartz MS. Assessing illicit drug use
among adults with schizophrenia. Psychiatry Research 2012; doi
10.1016/j.psychres.2012.05.028.
Desmarais SL, Van Dorn RA, Sellers BG, Young MS, Swartz MS. Accuracy of self-report,
biological tests, collateral reports and clinician ratings for identifying substance use disorders
among adults with schizophrenia. Psychology of Addictive Behaviors. 2012; Advance online
publication. doi: 10.1037/a0031256
24
235. Swartz MS, Swanson JW. Can States Implement Involuntary Outpatient Commitment Within
Existing State Budgets? Psychiatric Services 2013; 64 (1): 7-9. ps.psychiatryonline.org
236. Elbogen EB, Bradford, DW, Swartz, MS. A Recovery-oriented Money Management
Intervention. Psychiatric Services 2013; 62 (1): 99.
237. Wu LT, Gersing KR, Swartz MS, Burchett B, Li TK, Blazer DG. Using electronic health
records to assess comorbidities of substance use and psychiatric diagnoses and treatment
settings among adults. Journal of Psychiatric Research. 2013; 47:555-563.
238. Arnold JG, Miller AL, Canive JM, Rosenheck RA, Swartz MS, Mintz J. Comparison of
outcomes for African Americans, Hispanics & Non-Hispanic Whites in CATIE Study.
Psychiatric Services. 2013; doi: 10.1176/appi.ps.002412012.
239. Swanson JW, Frisman LK, Robertson AG, Lin HJ, Trestman RL, Shelton DA, Parr K, Rodis
E, Buchanan A, Domino M, Swartz MS. Costs of criminal justice involvement among
persons with serious mental illness in Connecticut. Psychiatric Services. 2013; doi:
10.1176/appi.ps.002212012.
240. Van Dorn R, Desmarais SL, Tueller SJ, Jolley JM, Johnson KL, Swartz MS. Drug and
alcohol trajectories among adults with schizophrenia: Data from the CATIE Study.
Schizophrenia Research. 2013; doi: 10.1016/j.schres.2013.05.006.
241. Wu LT, Blazer DG, Swartz MS, Burchett B, Brady KT, NIDA AAPI Workgroup. Illicit and
nonmedical drug use among Asian Americans, Native Hawaiians/Pacific Islanders and
mixed-race individuals. Drug and Alcohol Dependence. 2013 Jul 23; doi:
10.1016/j.drugalcdep.2013.06.008.
242.
In press:
1. Salkever D, Karakus M, Slade E, Harding C, Hough R, Rosenheck R, and Medstat Group/USSCAP study (Swartz M). Community-based employment and earnings of persons with
schizophrenia: Evidence on descriptors and predictors from a large naturalistic study.
Psychiatric Services.
2. Reif SS, Pence BW, LeGrand S, Wilson ES, Swartz M, Ellington T, Whetten K. In-home
Mental Health Treatment for Individuals with HIV. AIDS Patient Care and STDs.
3. Strauss JL, Zervakis JB, Stechuchak KM, Olsen MK, Swanson J, Swartz MS, Weinberger M,
Marx CE, Calhoun PS, Butterfield MI, Oddone EZ. Adverse impact of coercive treatments on
psychiatric inpatients’ satisfaction with care. Community Mental Health Journal.
Submitted for Review:
1. Ascher-Svanum H, Zhu B, Faries D, Ernst F, Swartz M, Swanson J. Efficacy versus
effectiveness of antipsychotic medications in the treatment of schizophrenia: Clinical trials
versus usual practice. Psychiatric Services.
2. Conover CJ, Ostermann J, Bouis S, Whetten R, Swartz M. Cost-effectiveness of integrated
25
3.
4.
5.
6.
services delivery for patients in North Carolina living with combined HIV/AIDS, chronic
mental illness and substance abuse disorders. Health Services Research.
Elbogen EB, Newton V, Swanson JW, Swartz MS, Marson DC. Age, cognition, and financial
capacity in psychiatric disabilities: Implications for clinical practice. International Journal of
Forensic Mental Health.
Desmarais SL, Van Dorn RA, Sellers BG, Young MS, Swartz MS. Comparative and combined
utility of various approaches for identifying substance use disorders among adults with
schizophrenia. Addiction.
La EH, Zhu R, Lich KH, Ellis AR, Swartz M, Kosrok MR, Morrissey J. The effects of state
psychiatric hospital waitlist policies on length of stay and time to readmission. Psychiatric
Services.
Wu LT, Blazer DG, Gersing KR, Burchett B, Swartz MS, Mannelli P, NIDA AAPI
Workgroup. Comorbid substance use disorders with Axis I and II mental disorders among
Asian Americans, Native Hawaiians/Pacific Islanders, and mixed-race people. Psychiatric
Research.
Non-refereed publications:
1. Swartz MS, Blazer DG, George LK et al. Somatization disorder in a southern community.
Psychiatric Annals 1988; 18:335-339.
2. Swartz MS, Hargett AB, Fraker WW et al. The inpatient milieu: Structural and organization
principles. Psychiatric Annals 1988; 18:80-84.
3. Smith GR, Burns BJ, Little Rock Working Group on Mental and Substance Abuse Disorders in
Health-Care Reform. Recommendations of the Little Rock Working Group on Mental and
Substance Abuse Disorders in Health-Care Reform. Journal of Mental Health Administration
1993; 20:247-253.
4. Kessler RC, McGonagle KA, Swartz M, Blazer DG, Nelson CB. Sex and depression in the
National Comorbidity Survey I: Lifetime prevalence, chronicity and recurrence in Year Book of
Psychiatry & Applied Mental Health Annual. Edited by JA Talbott. 1995; 7:193.
5. Swartz MS, Olfson M, Carpenter D, Kahn DA, Frances A. Policy issues in Treatment of
Schizophrenia 1999. Edited by JP McEvoy, PL Scheifler & A Frances. Journal of Clinical
Psychiatry supp. 11, 1999; 60: 30-72.
6. Stroup TS, Lieberman JA, Swartz MS, McEvoy JP. Comparative effectiveness of antipsychotic
drugs in schizophrenia. Dialogues in Clinical Neuroscience, 2000; 2(4):373-379.
7. Swanson JW, Swartz MS, Borum R, Hiday VA, Wagner HR, Burns BJ. Involuntary outpatient
commitment and reduction of violent behavior in persons with severe mental illness. Year
Book of Psychiatry & Applied Mental Health 2001:173-174.
8. Swartz MS, Swanson JW, Wagner HR, Burns BJ, Hiday VA, Borum R. Can involuntary
outpatient commitment reduce hospital recidivism?: Findings from a randomized trial with
severely mentally ill individuals. Year Book of Psychiatry & Applied Mental Health 2001:171172.
9. Elbogen E, Swanson JW, Swartz MS. Violence risk management and adherence to treatment
with atypical antipsychotics in schizophrenia. Behavioral Health Management 2004; 24(6):S126
S4.
10. Swartz MS, McEvoy JP. PRO/CON: Psychosocial intervention, not pharmacotherapy is the
effective approach to substance abuse in schizophrenia. Psychotic Disorders 2005; 9(3); 14-15.
11. Swartz MS, Swanson JW, Steadman HJ, Robbins PC, Monahan J. New York State Assisted
Outpatient Treatment Program Evaluation. Duke University School of Medicine, Durham, NC,
June, 2009.
12. Buchanan A, Binder R, Norko M, Swartz M. Psychiatric violence risk assessment. American
Journal of Psychiatry 2012; 169:340. 10.1176/appi.ajp.2012.169.3.340
Chapters in books:
1. Swartz MS. Anxiety disorders in Essentials of Clinical Psychiatry. Edited by J.I. Walker.
Philadelphia: Lippincott, 1985.
2. Swartz MS, Blazer DG. The distribution of affective disorder in the elderly in Affective
Disorders in the Elderly. Edited by E. Murphy. London: Churchill Livingston, 1986.
3. Swartz MS, Landerman R, George LK et al. Somatization disorder in Psychiatric Disorders
in America. Edited by L. Robins and D. Regier. New York: The Free Press, 1991.
4. Blazer DG, Hughes D, George LK, Swartz MS et al. Generalized anxiety disorder in
Psychiatric Disorders in America. Edited by L. Robins & D. Regier. New York: The Free
Press, 1991.
5. Escobar JI, Swartz MS, Rubio-Stipec M et al. Medically unexplained symptoms:
Distribution, risk factors, and comorbidity in Current Concepts of Somatization: Research
and Clinical Perspectives. Edited by L.J. Kirmayer & J.M. Robbins. Washington: APA
Press, 1991.
6. Swartz MS. Personality disorders in Geriatric Review Syllabus. Edited by American
Geriatric Society, 1991.
7. Swartz MS, Sibert T. Should it be easier to involuntarily commit individuals to treatment?
Controversial Issues in Mental Health. Edited by S.A. Kirk & S.D. Einbinder. New York:
Allyn & Bacon, 1994.
8. Sibert T, Swartz MS. Personality disorders in the elderly in The Psychiatry of Old Age: An
International Textbook. Edited by J.R.M. Copeland, M.T. Abou-Saleh, & D.G. Blazer.
Chichester: John Wiley and Sons, 1994.
9. Tiihonen J, Swartz MS. Pharmacological intervention for preventing violence among the
mentally ill with secondary alcohol and drug-use disorders in Violence among the Mentally
Ill: Effective Treatments and Management Strategies. Edited by S. Hodgins. Dordrecht, The
Netherlands: Kluwer Academic Publishers, 2000.
10. Swanson J, Swartz M, Borum R, Hiday V, Wagner H, Burns BJ. Involuntary outpatient
commitment and reduction of violent behavior in persons with severe mental illness in Year
Book of Psychiatry and Applied Mental Health. Edited by J. Talbott. New York: Elsevier,
2001.
11. Borum R, Swartz M, Swanson J, Wiseman S. Compliance with remediation attempts in HCR
– 20 Violence Risk Management Companion Guide. Edited by K.S. Douglas, C.D. Webster,
27
S.D. Hart, D. Eaves, & J.R.P. Ogloff. Burnaby, B.C.: Mental Health, Law, and Policy
Institute, Simon Fraser University, 2002.
12. Swartz MS, Swanson JW. Involuntary out-patient commitment in the United States: Practice
& controversy in Care of the Mentally Disordered Offender in the Community. Edited by A.
Buchanan. New York: Oxford University Press, 2002.
13. Mankad MV, Swartz MS. Medication compliance in Psychiatry: Behavioral Sciences and
Clinical Essentials, 2nd edition. Edited by A. Tasman and J.A. Lieberman. London: John
Wiley & Sons, 2002.
14. Hiday VA, Swartz MS, Swanson JW, Borum R. Coercion in mental health care in Ethics in
Community Mental Health Care: Commonplace Concerns. Edited by P. Blacklar and D.L.
Cutler. New York City: Kluwer Academic/Plenum Publishers, 2002.
15. Swartz MS, Lauriello J, Drake RE. Psychosocial therapies in American Psychiatric
Publishing Textbook of Schizophrenia. Edited by J.A. Lieberman, T.S. Stroup & D.O.
Perkins. Washington, DC: American Psychiatric Publishing, Inc., 2006.
16. Reimherr F, Swartz MS, Olsen JL. Substance use in persons with schizophrenia: Incidence,
baseline correlates, and effects on outcome in the NIMH CATIE study in Quality of Life and
Recovery for Antipsychotic Drugs in Schizophrenia: The CATIE Project. Edited by S. Stroup
& J. Lieberman. Cambridge: Cambridge University Press, 2010.
17. Swartz MS. Psychosocial functioning in patients with chronic schizophrenia: Findings from
the NIMH CATIE study in Antipsychotic Trials in Schizophrenia: The CATIE Project.
Edited by S. Stroup & J. Lieberman. Cambridge: Cambridge University Press, 2010.
18. Swartz MSS, Frohberg NR, Drake RE, Lauriello J. Psychosocial Therapies in Essentials of
Schizophrenia. Edited by J.A. Lieberman, T.S. Stroup & D.O. Perkins. Washington,
DC:American Psychiatric Publishing, Inc, 2012.
19. Swanson JW, Robertson AG, Frisman LK, Norko MA, Lin HJ, Swartz MS, Cook PJ.
Preventing gun violence involving people with serious mental illness in Reducing Gun
Violence in America: Informing Policy with Evidence and Analysis. Edited by D.W. Webster
& J.S. Vernick. Baltimore, MD: The Johns Hopkins University Press, 2012.
4) Submitted for publication: None
5) Books: None
6) Other:
1. Swartz MS. Involuntary Civil Commitment. Dial Access, Southern Medical Association,
1993.
2. Swartz MS. The Right To Refuse Treatment. Dial Access, Southern Medical Association,
1993.
3. Burns BJ, Swartz MS (Executive Producers); Harron B (Producer). Hospital Without Walls
(videotape).
Dept. of Psychiatry, Duke University Medical Center, Durham, NC, 1993.
1. Swartz MS (Executive Producer), Harron B (Producer). Uncertain Journey (videotape). Dept.
28
of Psychiatry, Duke University Medical Center, Durham, NC, 1995.
2. Swartz MS (Executive Producer), Harron B (Producer). Never Too Far: Rural Outreach for
Severe Mental Illness (videotape). Dept. of Psychiatry, Duke University Medical Center,
Durham, NC, 1999.
3. Swartz MS (Executive Producer), Harron B (Producer). Go For It: Careers in Healthcare
(videotape). Duke AHEC Program, Duke University Medical Center, Durham, NC, 2000.
4. Swartz MS, Monahan J, Appelbaum PS. Confusion about outpatient commitment. [Letter].
Psychiatric Services 52(8):1103-1104, 2001.
Selected Presentations (2005-present):
1. Time to All-Cause Discontinuation of Atypical versus Typical Antipsychotics in the
Naturalistic Treatment of Schizophrenia. International Congress on Schizophrenia Research.
Savannah, GA, April 6, 2005.
2. Testimony to the NY Assembly Standing Committees on: Mental Health, Mental Retardation
and Developmental Disabilities and Codes in Reference to the Renewal of Kendra’s Law.
New York, NY, April 8, 2005.
3. Use of Psychiatric Advance Directives to Promote Self-determination. 24th Semi-annual
Mental Health and the Law Symposium, Roanoke, VA, April 15, 2005.
4. Inpatient and Outpatient Commitment: Understanding the Legal and Clinical Issues. Area L
AHEC, Rocky Mount, NC, May 3, 2005.
5. Access to Medical Care for Persons with Severe Mental Illness and Hepatitis C and Related
Disorders. American Psychiatric Association 158th Annual Meeting, May 23, 2005.
6. Psychiatrists’ Attitudes about Their Clinical, Legal and Ethical Obligations under Psychiatric
Advance Directives. American Psychiatric Association 158th Annual Meeting, May 25, 2005.
7. Psychiatric Advance Directives Informational Session. Partners for Progress in Advance Care
Planning and Alamance Regional Medical Center Behavioral Medicine, Burlington, NC, June
14, 2005.
8. Mental Health Issues in North Carolina. Rural Health Group: Kate B. Reynolds Charitable
Trust, Winston Salem, NC, September 23, 2005.
9. Involuntary Outpatient Commitment: What’s in the Data? American Academy of Psychiatry
and the Law Annual Meeting. Montreal, Canada. October 27, 2005.
10. Mandated Community Treatment for Severe Mental Illness: Should we do it? Neuroscience
Grand Rounds, Rush University Medical Center. Chicago, IL, November 16, 2005.
11. Understanding Factors in Treatment Discontinuation in Schizophrenia. Teleconference:
PeerView Initiative. University of FL, January 19, 2006.
12. Treatment Adherence in Persons with Schizophrenia. Neuroscience Grand Rounds, Utah
State Hospital, Provo, UT, January 26, 2006.
13. Comparative Effectiveness of Antipsychotic Drugs: Results from the NIMH CATIE Trial.
Nevada Psychiatric Association’s 11th Annual Psychopharmacology Update. Las Vegas, NV,
February 18, 2006.
14. Evidence-Based Practices for Persons with Severe Mental Illness. Sandhills Center LME,
Carthage, NC, February 20, 2006.
29
15. N.C. Mental Health Reform. Radio interview “The State of Things”, UNC-NPR, March 20,
2006.
16. Acute Psychosis. Wake AHEC Outreach Lecture, Person Memorial Hospital. Roxboro, NC,
March 21, 2006.
17. Crisis Services: Issues of Access for the most needy clients. Western N.C. Symposium on
Mental Health and Substance Abuse. Asheville, NC, April 3, 2006.
18. CATIE Trial and Potential Impact on Clinical practice. National Forum on Medical
Comorbities and Metabolic Disturbances in the Mentally Ill. Chicago, IL, April 8, 2006.
19. Mental Health/Substance Abuse Disparities: Who is responsible? Panelist, “Real People
Issues: N.C. Summit”, Durham, NC, April 24, 2006.
20. Adverse impact of involuntary hospitalization on perceptions of psychiatric care in veterans
with severe mental illness. Poster presented at the 2006 American Psychiatric Association
Annual Meeting. Toronto, Canada, May 2006.
21. Results and lessons from the CATIE Schizophrenia Trial. 12th Annual Santa Fe Psychiatric
Symposium, Santa Fe, NM, June 28, 2006.
22. Advance Directives for Psychiatric Patients. Cape Fear Valley Health System. Fayetteville,
NC, August 22, 2006.
23. What the Research Says. Panelist - A Discussion of Mandated Community Treatment and
New Mexico’s Behavioral Health Needs. New Mexico Behavioral Health Collaborative.
Albuquerque, NM, August 31, 2006.
24. The CATIE Schizophrenia Trial: Findings to date. 58th Institute on Psychiatric Services. New
York, NY, October 6, 2006.
25. Creating a Virtual Community of Interest: National Resource Center on Psychiatric Advance
Directives. Alternatives 2006 Conference. Portland, OR, October 26, 2006.
26. Comparative Effectiveness of Antipsychotic Drugs: Interpreting the Results of the CATIE
Study. ACNP Annual Meeting. Hollywood, FL, December 4, 2006.
27. CATIE: A Critical Analysis. CATIE Investigators’ Educational Series, Baltimore, MD,
December 9, 2006.
28. Clinical Factors When Treating Patients with Schizophrenia: New Insights and Practical
Implications. CATIE Investigators’ Educational Series. Baltimore, MD, December 9, 2006.
29. Assisted Outpatient Treatment/Involuntary outpatient Commitment: What’s in the Data?
Virginia Association of Community Service Boards, Richmond, VA, January 10, 2007.
30. CATIE: A Critical Analysis. CATIE Educational Series. Washington D.C., January 27, 2007.
31. Clinical Factors When Treating Patients with Schizophrenia: New Insights and Practical
Implications, CATIE Educational Series, Washington D.C., January 27, 2007.
32. CATIE: A Critical Analysis. CATIE Educational Series, Long Beach, CA, February 10,
2007.
33. Clinical Factors When Treating Patient with Schizophrenia: New Insights and Practical
Implications. CATIE Educational Series, Long Beach, CA, February 10, 2007.
34. CATIE: A Critical Analysis. CATIE Educational Series, San Francisco, CA, February 11,
2007.
35. Clinical Factors When Treating Patient with Schizophrenia: New Insights and Practical
Implications. CATIE Educational Series, San Francisco, CA, February 11, 2007.
30
36. Psychiatric Advance Directives. Clinical Update 2007 and AACP Winter Meeting. Pinehurst,
NC, February 22, 2007.
37. CATIE: A Critical Analysis. CATIE Educational Series, New York, NY, March 10, 2007.
38. Clinical Factors When Treating Patient with Schizophrenia: New Insights and Practical
Implications. CATIE Educational Series, New York, NY, March 10, 2007.
39. Reforming Civil Commitment: Recent Trends and Lessons. Mental Health and the Law
Symposium: Civil Commitment Reform in Virginia. Charlottesville, VA, March 16, 2007.
40. Assisted Outpatient Treatment/Involuntary Outpatient Commitment: What’s in the Data? 37th
Annual National Council for Community Behavioral Healthcare Conference, Las Vegas, NV,
March 26, 2007.
41. New Research on Anti-Psychotic Medication: Effectiveness, Cost-Effectiveness and Liability
Risks. The 12th P. Browning Hoffman Memorial Lecture in Law and Psychiatry, Department
of Psychiatry and Neurobehavioral Sciences. University of Virginia, Charlottesville, VA,
April 10, 2007.
42. Assisted Outpatient Treatment/Involuntary Outpatient Commitment: What’s in the Data?
Current State of Involuntary Mental Health Treatment in the District of Columbia, D.C.
Department of Mental Health and the Department of Psychiatry, Georgetown University
Hospital. Washington, D.C., April 27, 2007.
43. Court-Ordered Outpatient Mental Health Treatment: The Data and the Controversy. Members
of Parliament. London, England, June 4, 2007.
44. Involuntary Outpatient Treatment: The Data and Controversy. Workshop: Outcomes and
Adverse Effects of Coercive Treatment Measures. WPC Thematic Conference on “Coercive
Treatment in Psychiatry: A Comprehensive Review”, Dresden, Germany, June 6, 2007.
45. Keynote Speaker: Balancing Public Health & Individual Liberties: Exploring New Options in
Outpatient Treatment, University of Maryland School of Law, April 25, 2010.
46. Assessing Involuntary Outpatient Treatment, International Association for Forensic Mental
Health Services, Vancouver, Canada, May 25, 2010.
47. Keynote Speaker, Involuntary Outpatient Treatment, Forensic Meeting, Royal College of
Psychiatry, Berlin, Germany, February 10, 2011.
48. Carle Taube Sward Speaker, American Public Health Association Annual Meeting,
Washington, DC, November 2, 2011.
49. Chair & presenter: Assisted Outpatient Treatment for Persons with Severe Mental Illness:
The data and the controversy. Symposium presented at the 2012 American Psychiatric
Association Annual Meeting, Philadelphia PA, May 8, 2012.
31